1. Home
  2. ITRM vs MGN Comparison

ITRM vs MGN Comparison

Compare ITRM & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • MGN
  • Stock Information
  • Founded
  • ITRM 2015
  • MGN 2020
  • Country
  • ITRM Ireland
  • MGN Malaysia
  • Employees
  • ITRM N/A
  • MGN N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • MGN
  • Sector
  • ITRM Health Care
  • MGN
  • Exchange
  • ITRM Nasdaq
  • MGN Nasdaq
  • Market Cap
  • ITRM 40.0M
  • MGN 43.0M
  • IPO Year
  • ITRM 2018
  • MGN 2025
  • Fundamental
  • Price
  • ITRM $0.48
  • MGN $2.16
  • Analyst Decision
  • ITRM Strong Buy
  • MGN
  • Analyst Count
  • ITRM 1
  • MGN 0
  • Target Price
  • ITRM $9.00
  • MGN N/A
  • AVG Volume (30 Days)
  • ITRM 1.2M
  • MGN 51.8K
  • Earning Date
  • ITRM 11-14-2025
  • MGN 12-09-2025
  • Dividend Yield
  • ITRM N/A
  • MGN N/A
  • EPS Growth
  • ITRM N/A
  • MGN N/A
  • EPS
  • ITRM N/A
  • MGN 0.07
  • Revenue
  • ITRM $390,000.00
  • MGN $13,484,571.00
  • Revenue This Year
  • ITRM N/A
  • MGN N/A
  • Revenue Next Year
  • ITRM $482.25
  • MGN N/A
  • P/E Ratio
  • ITRM N/A
  • MGN $26.63
  • Revenue Growth
  • ITRM N/A
  • MGN N/A
  • 52 Week Low
  • ITRM $0.36
  • MGN $1.30
  • 52 Week High
  • ITRM $3.02
  • MGN $8.63
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 41.91
  • MGN N/A
  • Support Level
  • ITRM $0.36
  • MGN N/A
  • Resistance Level
  • ITRM $0.49
  • MGN N/A
  • Average True Range (ATR)
  • ITRM 0.05
  • MGN 0.00
  • MACD
  • ITRM -0.00
  • MGN 0.00
  • Stochastic Oscillator
  • ITRM 43.47
  • MGN 0.00

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About MGN Megan Holdings Limited Ordinary Shares

Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.

Share on Social Networks: